We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Risk of insulin resistance with statin therapy in individuals without dyslipidemia: A propensity‐matched analysis in a registry population.
- Authors
Hyun, Myung Han; Jang, Jae Won; Choi, Byoung Geol; Na, Jin Oh; Choi, Cheol Ung; Kim, Jin Won; Kim, Eung Ju; Rha, Seung‐Woon; Park, Chang Gyu; Lee, Eunmi; Seo, Hong Seog
- Abstract
Several studies suggest the higher vulnerability of individuals with lower low‐density lipoprotein cholesterol (LDL‐C) levels to diabetes mellitus. However, the discordance between high and low baseline LDL‐C levels shown by statin‐induced insulin resistance is not fully understood. This study aimed to explore the relationship between baseline LDL‐C levels and the risk of statin‐induced insulin resistance during statin therapy. In total, 2660 (451 with dyslipidemia and 2209 without dyslipidemia) consecutive patients were enrolled. Their baseline clinical data were adjusted using a propensity score matching analysis, using the logistic regression model. Insulin resistance index was based on the homeostatic model assessment‐insulin resistance (HOMA‐IR) and was monitored for a median of 2 years. Among the individuals who received statin therapy, those with and without dyslipidemia showed significantly decreased LDL‐C levels (all P <.0001) and significantly increased fasting plasma insulin levels (Δ = +24.1%, P =.0230; Δ = +30.1%, P <.0001); however, their glycated haemoglobin A1c and fasting blood glucose levels did not change (all P >.05). Although HOMA‐IR was positively associated with statin therapy in individuals with and without dyslipidemia, statistically significant difference during follow‐ups was observed only in individuals without dyslipidemia (Δ = +15.6%, P =.1609; Δ = 24.0%; P =.0001). Insulin resistance was higher in statin users without baseline dyslipidemia than in those with dyslipidemia. Thus, statin therapy could increase the risk of statin‐induced insulin resistance in individuals with normal baseline cholesterol levels.
- Subjects
INSULIN resistance; LOW density lipoproteins; PROPENSITY score matching; BLOOD sugar; DIABETES
- Publication
Clinical & Experimental Pharmacology & Physiology, 2020, Vol 47, Issue 6, p947
- ISSN
0305-1870
- Publication type
Article
- DOI
10.1111/1440-1681.13272